Home

Andrew J Greenfield

CIK 1372715 · VP, CHIEF COMMERCIAL OFFICER · last filed 2022-12-27

Andrew J Greenfield is a VP, CHIEF COMMERCIAL OFFICER who has filed 93 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is −$30.4M, making them a net seller over the disclosed history. 98 SEC filings were submitted jointly with ABIOMED INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

93

Lifetime Open-Market Net

-$30.38M

Filer Profile

Reported Address
14 HILLSIDE DRIVE
GEORGETOWN, MA 01833
Phone
(978) 352-3815
Related Filers
ABIOMED INC — 98 joint filings, latest 2022-12-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABIOMED INC (ABMD) Delisted VP, CHIEF COMMERCIAL OFFICER 28,009 $381.02 $10.67M -$16.06M 38 2022-12-20
ABIOMED INC (APOL) Delisted VP Healthcare Solutions 56,307 — — -$14.32M 54 2016-12-14

Recent Filings

93 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-12-27 — Mixed −23,484 $0
2022-12-20 ABIOMED INC (ABMD) Delisted Grant (A) +14 $0 EDGAR
2022-11-08 ABIOMED INC (ABMD) Delisted Tax (F) −1,548 -$578.9K EDGAR
2022-10-04 ABIOMED INC (ABMD) Delisted Grant (A) +34 $0 EDGAR
2022-05-31 ABIOMED INC (ABMD) Delisted Mixed +6,178 -$351.6K EDGAR
2022-05-27 ABIOMED INC (ABMD) Delisted Tax (F) −302 -$75.3K EDGAR
2022-04-04 ABIOMED INC (ABMD) Delisted Grant (A) +25 $0 EDGAR
2021-11-05 ABIOMED INC (ABMD) Delisted Mixed +5,426 -$541.8K EDGAR
2021-10-04 ABIOMED INC (ABMD) Delisted Grant (A) +26 $0 EDGAR
2021-06-02 ABIOMED INC (ABMD) Delisted Tax (F) −366 -$104.2K EDGAR
Showing 1–10 of 93
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.